Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immune landscape of common CNS malignancies: implications for immunotherapy
Martina Ott, Robert M. Prins, Amy B. Heimberger
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 11, pp. 729-744
Closed Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Multimodal data fusion for cancer biomarker discovery with deep learning
Sandra Steyaert, Marija Pizurica, Divya Nagaraj, et al.
Nature Machine Intelligence (2023) Vol. 5, Iss. 4, pp. 351-362
Open Access | Times Cited: 134
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial
Richard G. Everson, Willy Hugo, Lu Sun, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them
Karl J. Habashy, Rana Mansour, Charbel Moussalem, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 6, pp. 976-987
Open Access | Times Cited: 46
Co-delivery of phagocytosis checkpoint and STING agonist by a Trojan horse nanocapsule for orthotopic glioma immunotherapy
Ying Zhou, Yuxin Guo, Lufei Chen, et al.
Theranostics (2022) Vol. 12, Iss. 12, pp. 5488-5503
Open Access | Times Cited: 39
Localization of protoporphyrin IX during glioma-resection surgery via paired stimulated Raman histology and fluorescence microscopy
Mustafa Nasir-Moin, Lisa I. Wadiura, Vlad Sacalean, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 6, pp. 672-688
Closed Access | Times Cited: 10
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma
Hinda Najem, Spencer Lea, Shashwat Tripathi, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 12
Open Access | Times Cited: 8
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Immuno-oncologic profiling of pediatric brain tumors reveals major clinical significance of the tumor immune microenvironment
Adrian Levine, Liana Nobre, Anirban Das, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
Lizhi Pang, Fatima Khan, Amy B. Heimberger, et al.
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 839-854
Open Access | Times Cited: 37
Immunostimulant In Situ Hydrogel Improves Synergetic Radioimmunotherapy of Malignant Glioblastoma Relapse Post‐Resection
Shuo Sun, Wei Gu, Haisi Wu, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 43
Open Access | Times Cited: 33
Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy
Daoyuan Xie, Yaomei Tian, Die Hu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Clinical and Translational Advances in Glioma Immunotherapy
Lukas Bunse, Theresa Bunse, Christopher M. Kramer, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1799-1817
Open Access | Times Cited: 27
A map of the spatial distribution and tumour‐associated macrophage states in glioblastoma and grade 4 IDH‐mutant astrocytoma
Wen Yin, Yi‐Fang Ping, Fei Li, et al.
The Journal of Pathology (2022) Vol. 258, Iss. 2, pp. 121-135
Closed Access | Times Cited: 26
Roles of the m6A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell Analyses
Feng Yuan, Xiangming Cai, Zixiang Cong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Bacteria-mediated metformin-loaded peptide hydrogel reprograms the tumor immune microenvironment in glioblastoma
Lisheng Zhu, Jingyu Liu, Meng-jun Qiu, et al.
Biomaterials (2022) Vol. 288, pp. 121711-121711
Open Access | Times Cited: 23
Understanding current experimental models of glioblastoma-brain microenvironment interactions
Niket Yadav, Benjamin Purow
Journal of Neuro-Oncology (2024) Vol. 166, Iss. 2, pp. 213-229
Open Access | Times Cited: 5
Cerium Vanadate Nanozyme with pH-Dependent Dual Enzymatic Activity for Glioblastoma Targeted Therapy and Postradiotherapy Damage Protection
Xiao Han, Boyan Li, Wenhan Wang, et al.
ACS Nano (2024)
Open Access | Times Cited: 5
Nanomaterials with changeable physicochemical property for boosting cancer immunotherapy
Qiankun Ni, Fengfei Xu, Yufei Wang, et al.
Journal of Controlled Release (2022) Vol. 342, pp. 210-227
Closed Access | Times Cited: 22
Imaging phenotypes from MRI for the prediction of glioma immune subtypes from RNA sequencing: A multicenter study
Jingxian Duan, Zhenyu Zhang, Yinsheng Chen, et al.
Molecular Oncology (2023) Vol. 17, Iss. 4, pp. 629-646
Open Access | Times Cited: 11
Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma
Bing Lu, Tianyi Lu, Jiawen Shi, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 5, pp. 772-784
Open Access | Times Cited: 4
Comprehensive Analysis Identifies THEMIS2 as a Potential Prognostic and Immunological Biomarker in Glioblastoma
Jianan Chen, Qiong Wu, Anders Berglund, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 66-66
Open Access
Ultrasonic Aspiration-Acquired Glioblastoma Tissue Preserves Lymphocyte Phenotype and Viability, Supporting Its Use for Immunological Studies
Εftychia Stavrakaki, Zineb Belcaid, Rutger K. Balvers, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 603-603
Open Access
Clinical management of checkpoint inhibitor pneumonitis: Focus, challenges, and future directions
Yan Xu, Ruxuan Chen, Ruili Pan, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2025) Vol. 3, Iss. 1, pp. 29-40
Open Access
Page 1 - Next Page

Scroll to top